Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
916.25
-10.90 (-1.18%) Natco Pharma informs about disclosure
Date: 20-08-2021Natco Pharma has informed that it enclosed the disclosure titled ‘Legal update on Ibrutinib’ under Regulation 30 of SEBI (LODR) Regulations 2015.
The above information is a part of company’s filings submitted to BSE.